The Uveitis Market To Revitalize Post Covid-19 (2024 Onwards)

Posted by Ashish on December 31st, 2020

The US$ 497 Mn uveitis treatment market is likely to expand at a stable CAGR of 6.5% over the next eight years. In 2017, the market is expected to witness nearly 6.7% Y-o-Y growth over 2016. During 2016-2024, Persistence Market Research predicts a positive growth outlook for the global uveitis treatment market, influenced by several growth drivers, restraints, trends, and opportunities.

In its recently published report titled “Uveitis Treatment Market: Industry Analysis and Forecast, 2016–2024,” the company provides in-depth analysis of the market growth prospects for the eight-year assessment period, backing it up with historic and current market data.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3596

Company Profiles

• Allergan, Inc.,
• Bausch & Lomb Incorporated.
• Novartis AG (Alcon Laboratories Inc.)
• AbbVie Inc.
• Santen Pharmaceutical Co., Ltd
• Eyegate Pharmaceuticals, Inc.
• Alimera Sciences, Inc.
• pSivida Corp.